Zynex Inc. reported on October 1, 2025, that it will seek a commercialization partner for its NiCO™ CO-Oximeter, resulting in the termination of most Zynex Monitoring Solutions employees, incurring around $0.1 million in severance and up to $31 million in asset impairment charges.